Physician

Marc Travis Nuttall, MD

According to 2025 Medicare claims, Marc Nuttall, MD (NPI: 1144497322) practices hematology/oncology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84003-9998. Nuttall is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Nuttall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 143,318 HCPCS/CPT codes, and received $2,723,403 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,073 prescription claims across 177 beneficiaries totaling $2,693,286 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 47 claims. Open Payments data shows 100 records totaling $2,080. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,090,157 to $2,723,403. Similarly, Part D prescription costs have risen steadily, from $1,149,040 to $2,693,286. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.